Procter & Gamble reported net sales of US$21.2 billion in the third quarter of fiscal 2026, up 7% compared to the same period last year. Organic growth reached 3%, supported by a 2% increase in volume and a 1% rise in pricing, while sales mix remained neutral. Diluted earnings per share totaled US$1.63, an increase of 6%, while core EPS reached US$1.59, up 3%.
Among the business segments, Beauty stood out with 7% organic growth, driven by Hair Care and Personal Care. In the latter category, growth was supported by innovation, higher volumes and a favorable geographic mix. Skin Care also posted low double-digit growth, supported by a premium portfolio, partially offset by merchandising investments.
Health Care recorded 2% organic growth, while Fabric & Home Care increased 3%, and Baby, Feminine & Family Care also posted 3% growth. The Grooming segment reported modest growth of 1%, reflecting a balance between pricing gains and lower volumes.
The company also highlighted operating cash flow generation of US$4 billion and shareholder returns of US$3.2 billion during the quarter through dividends and share repurchases.
For fiscal year 2026, P&G maintained its sales and earnings growth outlook, expecting organic sales growth between flat and 4%, as well as core EPS growth within the same range. The company also reinforced additional investments in innovation and demand generation to support consumer performance amid a challenging macroeconomic and geopolitical environment.
